Multi-centre clinical study evaluating the efficacy of SonoVue (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples